Published in
Impact Journals, Oncotarget, 51(7), p. 84860-84871, 2016
DOI: 10.18632/oncotarget.12743
Links
Tools
Heregulin-expressing HER2-positive breast and gastric cancer exhibited heterogeneous susceptibility to the anti-HER2 agents lapatinib, trastuzumab and T-DM1
Journal article published in 2016 by
Yoshikane Nonagase,
Kimio Yonesaka,
Hisato Kawakami,
Satomi Watanabe,
Koji Haratani 
,
Takayuki Takahama ,
Naoki Takegawa,
Hiroto Ueda,
Junko Tanizaki,
Hidetoshi Hayashi,
Takeshi Yoshida,
Masayuki Takeda,
Yasutaka Chiba,
Takao Tamura,
Kazuhiko Nakagawa
and other authors.
,
Takayuki Takahama ,
Naoki Takegawa,
Hiroto Ueda,
Junko Tanizaki,
Hidetoshi Hayashi,
Takeshi Yoshida,
Masayuki Takeda,
Yasutaka Chiba,
Takao Tamura,
Kazuhiko Nakagawa
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 